col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Future Medicine: Future Virology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―12 Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses Jean-François Rossignol
2 [GO] 2022―Jan―12 Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour
3 [GO] 2021―Dec―15 A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt
4 [GO] 2021―Dec―15 Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak
5 [GO] 2021―Dec―15 Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn
6 [GO] 2021―Dec―06 Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey
7 [GO] 2021―Dec―03 Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, et al. (+5)
8 [GO] 2021―Nov―26 A brief review on DNA vaccines in the era of COVID-19 Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, et al. (+9)
9 [GO] 2021―Nov―26 Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh
10 [GO] 2021―Nov―26 Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi
11 [GO] 2021―Nov―12 Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, et al. (+2)
12 [GO] 2021―Nov―12 Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy Sayantan Laha, Raghunath Chatterjee
13 [GO] 2021―Nov―04 The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi
14 [GO] 2021―Nov―04 In-hospital clinical complications of COVID-19: a brief overview Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal
15 [GO] 2021―Nov―04 The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants Farid Rahimi, Amin Talebi Bezmin Abadi
16 [GO] 2021―Nov―04 SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system Tariq Khan, Syed Muhammad Jamal
17 [GO] 2021―Oct―29 The international treaty for pandemic preparedness and response: same story, different times? Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane
18 [GO] 2021―Oct―19 Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi
19 [GO] 2021―Oct―14 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni
20 [GO] 2021―Oct―08 Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? Lei Huang
21 [GO] 2021―Oct―08 A case series of pediatric COVID-19 with complicated symptoms in Iran Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, et al. (+3)
22 [GO] 2021―Sep―22 Association between blood groups and COVID-19 outcome in Iranian patients Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, et al. (+2)
23 [GO] 2021―Sep―21 High-value laboratory testing for hospitalized COVID-19 patients: a review Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, et al. (+8)
24 [GO] 2021―Sep―10 Fast evolution of SARS-CoV-2 driven by deamination systems in hosts Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, et al. (+2)
25 [GO] 2021―Sep―02 Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh
26 [GO] 2021―Sep―02 mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut
27 [GO] 2021―Aug―09 Harnessing immunological targets for COVID-19 immunotherapy Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
28 [GO] 2021―Jul―29 Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients Gerald Chi, Sahar Memar Montazerin, Jane J Lee
29 [GO] 2021―Jul―20 Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation Claudia Cava, Gloria Bertoli, Isabella Castiglioni
30 [GO] 2021―Jul―20 An overview of sex hormones in relation to SARS-CoV-2 infection Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani
31 [GO] 2021―Jul―20 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Eldar Muhtar, Mengyang Wang, Haimei Zhu
32 [GO] 2021―Jul―13 Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study Ajita Pandey, Mohit Sharma
33 [GO] 2021―Jul―13 Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh
34 [GO] 2021―Jul―08 Association of anemia and COVID-19 in hospitalized patients Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng
35 [GO] 2021―Jul―06 Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu
36 [GO] 2021―Jun―30 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan
37 [GO] 2021―Jun―22 The COVID-19 pandemic: an increased risk of rheumatoid arthritis Archana Tripathy, Nitish Swain, Bhawna Gupta
38 [GO] 2021―Jun―22 V483A: an emerging mutation hotspot of SARS-CoV-2 Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque
39 [GO] 2021―Jun―22 Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing
40 [GO] 2021―Jun―01 Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar
41 [GO] 2021―May―24 Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong
42 [GO] 2021―May―19 Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang
43 [GO] 2021―May―19 SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses Andrew P Rice, Jason T Kimata
44 [GO] 2021―May―12 Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, et al. (+8)
45 [GO] 2021―Apr―26 An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh
46 [GO] 2021―Apr―22 HIV and COVID-19 pandemic collision: turning challenges into opportunity Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli
47 [GO] 2021―Apr―21 Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram
48 [GO] 2021―Apr―14 The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period Hamid Tayebi Khosroshahi, Alireza Mardomi
49 [GO] 2021―Apr―07 Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, et al. (+5)
50 [GO] 2021―Apr―06 Xerostomia (dry mouth) in patients with COVID-19: a case series Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi
51 [GO] 2021―Mar―25 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee
52 [GO] 2021―Mar―24 The role of miRNAs in COVID-19 disease Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi
53 [GO] 2021―Mar―09 Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi
54 [GO] 2021―Mar―08 Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari
55 [GO] 2021―Mar―02 Computational guided approach for drug repurposing against SARS-CoV-2 Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai
56 [GO] 2021―Feb―24 Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, et al. (+3)
57 [GO] 2021―Feb―22 Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti
58 [GO] 2021―Feb―09 The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, et al. (+2)
59 [GO] 2021―Feb―04 What is the intermediate host species of SARS-CoV-2? Thomas Friend, Justin Stebbing
60 [GO] 2021―Feb―03 SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag
61 [GO] 2021―Jan―28 Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, et al. (+8)
62 [GO] 2021―Jan―26 Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, et al. (+6)
63 [GO] 2021―Jan―25 Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, et al. (+3)
64 [GO] 2021―Jan―13 Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini
65 [GO] 2021―Jan―07 A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols Michael L Hitchman
66 [GO] 2020―Dec―24 Relationship between IL-6 and COVID-19: to be considered during treatment Hafize Seda Vatansever, Eda Becer
67 [GO] 2020―Dec―16 Pandemic response management framework based on efficiency of COVID-19 control and treatment Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi
68 [GO] 2020―Dec―15 Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Yashwant Kumar, Reena Yadav, Alka Bhatia
69 [GO] 2020―Nov―30 Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig
70 [GO] 2020―Nov―26 The role of artificial intelligence in tackling COVID-19 Neelima Arora, Amit K Banerjee, Mangamoori L Narasu
71 [GO] 2020―Nov―26 Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh Nadim Sharif, Shuvra K Dey
72 [GO] 2020―Nov―04 LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Su M Metcalfe
73 [GO] 2020―Oct―28 A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, et al. (+3)
74 [GO] 2020―Oct―27 Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
75 [GO] 2020―Oct―22 Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng
76 [GO] 2020―Oct―14 A comprehensive review about SARS-CoV-2 SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed
77 [GO] 2020―Oct―13 Implications of current and future approaches to coronavirus disease 2019 testing Rasheid Smith, Sean M Geary, Aliasger K Salem
78 [GO] 2020―Oct―08 The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 Jaclyn Kelly Mann, Thumbi Ndung'u
79 [GO] 2020―Oct―08 In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan
80 [GO] 2020―Aug―26 Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan
81 [GO] 2020―Aug―26 Genetic and pathogenic characterization of SARS-CoV-2: a review Afsane Bahrami, Gordon A Ferns
82 [GO] 2020―Aug―18 A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra
83 [GO] 2020―Aug―17 Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid
84 [GO] 2020―Aug―12 Thoughts on detecting tissue distribution of potential COVID-19 receptors Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi
85 [GO] 2020―Jul―29 In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome Bader Y Alhatlani
86 [GO] 2020―Jul―27 COVID-19: studying the global pandemic - foreword Stefano Rusconi, Frederick G Hayden
87 [GO] 2020―Jul―27 Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem
88 [GO] 2020―Jun―26 COVID-19 in homeless populations: unique challenges and opportunities Brian Conway, David Truong, Kelli Wuerth
89 [GO] 2020―Jun―12 COVID-19 and coronaviral hepatitis: evidence of collateral damage Mohammad K Parvez
90 [GO] 2020―Jun―12 Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin
91 [GO] 2020―May―29 A suspected case of COVID-19 turned into a confirmed case: a case report from Iran Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, et al. (+5)
92 [GO] 2020―May―26 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise John Nemunaitis, Laura Stanbery, Neil Senzer
93 [GO] 2020―May―20 Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections Mona Fani, Ali Teimoori, Shokouh Ghafari
94 [GO] 2020―May―12 Prediction and analysis of key protein structures of 2019-nCoV Qihao Li, Wen Peng, Yu Ou
95 [GO] 2020―Apr―24 The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
96 [GO] 2020―Apr―17 Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.005 sec